The role of PGE2 in the differentiation of dendritic cells: How do dendritic cells influence T-cell polarization and chemokine receptor expression?

Stem Cells

Volumn 20, Issue 5, 2002, Pages 448-459

  Lee, Je Jung ^a,b   Takei, Masao ^c   Hori, Shinichi ^b   Inoue, Yoshiko ^d   Harada, Yukie ^b   Tanosaki, Ryuji ^b   Kanda, Yoshinobu ^b   Kami, Masayuki ^b   Makimoto, Atsushi ^b   Mineishi, Shin ^b   Kawai, Hiroyuki ^c   Shimosaka, Akihiro ^c   Heike, Yuji ^d   Ikarashi, Yoshinori ^d   Wakasugi, Hiro ^d   Takaue, Yoichi ^b   Hwang, Tai Ju ^a   Kim, Hyeoung Joon ^a   Kakizoe, Tadao ^b  

^a Chonnam National University Medical School   (South Korea)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c KIRIN BREWERY CO LTD   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Blood; Cell trafficking; Dendritic Cells; Th1 Th2

Indexed keywords

CALCIUM; CD1 ANTIGEN; CD14 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; CALCIUM TRANSPORT; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL POLARITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DENDRITIC CELL; HUMAN; HUMAN CELL; INFLAMMATION; NORMAL HUMAN; PHENOTYPE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TH1 CELL;

EID: 18544362362     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.20-5-448     Document Type: Article

References (33)

1. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9:271-296.
2. Hart DN. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 1997;90:3245-3287.
3. Avigan D. Dendritic cells: development, function and potential use for cancer immunotherapy. Blood Rev 1999;13:51-64.
4. Grabbe S, Kampgen E, Schuler G. Dendritic cells: multi-lineal and multi-functional. Immunol Today 2000;21:431-433.
5. Rissoan MC, Soumelis V, Kadowaki N et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999;283:1183-1186.
6. Vieira PL, de Jong EC, Wierenga EA et al. Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction. J Immunol 2000;164:4507-4512.
7. Trinchieri G, Scott P. The role of interleukin 12 in the immune response, disease and therapy. Immunol Today 1994;15:460-463.
8. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-252.
9. Tarte K, Klein B. Dendritic cell-based vaccine: a promising approach for cancer immunotherapy. Leukemia 1999;13:653-663.
10. O'Garra A, Murphy K. T-cell subsets in autoimmunity. Curr Opin Immunol 1993;5:880-886.
11. Davies P, Bailey PJ, Goldenberg MM et al. The role of arachidonic acid oxygenation products in pain and inflammation. Annu Rev Immunol 1984;2:335-357.
12. 2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J Immunol 1991;146:108-113.
13. 2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J Immunol 1993;150:5321-5329.
14. 2, promote Th2 responses. Adv Exp Med Biol 1997;417:363-367.
15. 2, promote type 2 cytokine production in maturing human naïve T helper cells. J Immunol 1997;159:28-35.
16. + dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. J Immunol 1998;161:2804-2809.
17. 2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production. J Exp Med 1997;186:1603-1608.
18. 2. Blood 1998;91:3112-3117.
19. Steinbrink K, Paragnik L, Jonuleit H et al. Induction of dendritic cell maturation and modulation of dendritic cell-induced immune responses by prostaglandins. Arch Dermatol Res 2000;292:437-445.
20. Cyster JG. Chemokines and cell migration in secondary lymphoid organs. Science 1999;286:2098-2102.
21. Sozzani S, Allavena P, Vecchi A et al. Chemokines and dendritic cell traffic. J Clin Immunol 2000;20:151-160.
22. Sozzani S, Allavena P, Vecchi A et al. The role of chemokines in the regulation of dendritic cell trafficking. J Leukoc Biol 1999;66:1-9.
23. Carramolino L, Kremer L, Goya I et al. Down-regulation of the beta-chemokine receptor CCR6 in dendritic cells mediated by TNF-alpha and IL-4. J Leukoc Biol 1999;66:837-844.
24. Yang D, Howard OM, Chen Q et al. Cutting edge: immature dendritic cells generated from monocytes in the presence of TGF-beta 1 express functional C-C chemokine receptor 6. J Immunol 1999;163:1737-1741.
25. Palucka KA, Taquet N, Sanchez-Chapuis F et al. Dendritic cells as the terminal stage of monocyte differentiation. J Immunol 1998;160:4587-4595.
26. Jonuleit H, Kuhn U, Muller G et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 1997;27:3135-3142.
27. von Andrian UH, Mackay CR. T-cell function and migration. Two sides of the same coin. N Engl J Med 2000;343:1020-1034.
28. Openshaw P, Murphy EE, Hosken NA et al. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J Exp Med 1995;182:1357-1367.
29. + T cell differentiation. J Immunol 1997;159:5956-5963.
30. Mosca PJ, Hobeika AC, Clay TM et al. A subset of human monocyte-derived dendritic cells expresses high levels of interleukin-12 in response to combined CD40 ligand and interferon-gamma treatment. Blood 2000;96:3499-3504.
31. Tanaka H, Demeure CE, Rubio M et al. Human monocyte-derived dendritic cells induce naïve T cell differentiation into T helper cell type 2 (Th2) or Th1/Th2 effectors. Role of stimulator/responder ratio. J Exp Med 2000;192:405-412.
32. Lee SP, Tierney RJ, Thomas WA et al. Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy. J Immunol 1997;158:3325-3334.
33. Zou W, Borvak J, Marches F et al. Macrophage-derived dendritic cells have strong Th1-polarizing potential mediated by beta-chemokines rather than IL-12. J Immunol 2000;165:4388-4396.